🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 7 of 78

  1. US 11733191

    Closed-loop controlled chemical apparatus

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11730705

    Small molecule CMKLR1 antagonists in inflammatory disease

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11730799

    Cancer vaccines and methods of producing and using same

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11725248

    Evaluation of mantle cell lymphoma and methods related thereto

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11723923

    Methods of preparing T cells for T cell therapy

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11723887

    Process to prepare treprostinil, the active ingredient in Remodulin®

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11723943

    Therapeutic use of chardonnay seed products

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11723362

    Broad-spectrum synergistic antimicrobial compositions

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11718647

    Virus-like particles and methods of use

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11707434

    Method for preparing organic solvent-free lyophilized cyclophosphamide

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11707459

    Method for treating nervous system injuries using boldine and analogs thereof

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11702417

    Compounds for improving mRNA splicing

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11696922

    Nanoparticle to target cancer

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11697676

    Anti-human papillomavirus 16 E6 T cell receptors

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11696903

    Compounds and methods for scavenging dicarbonyl electrophiles

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11690894

    Transgenic corn with antifungal peptide AGM182 (DN:0113.18)

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11691992

    Oxaborole analogs and uses thereof

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11690895

    Compositions and methods of interferon alpha binding proteins

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11692010

    Compounds that bind to human immunodeficiency virus rev response element

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11690901

    Southern cattle tick vaccine product

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11684572

    Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11686735

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11684597

    Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11679150

    Mycoplasma bovis vaccine product

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11680093

    Monoclonal antibodies that specifically bind to matrilin 3 and their use

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11680079

    Nucleic acid aptamers to treat histone-induced disease states

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11679121

    Morpholino oligonucleotides useful in cancer treatment

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11679151

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11679128

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11673853

    Small molecule AMPK activators

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11672775

    Treprostinil prodrugs

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11672801

    Compositions and methods for treating cancer

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11672811

    Materials and methods for suppressing and/or treating bone related diseases and symptoms

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11672876

    Imageable embolic microsphere

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11672863

    Enhanced solubility drug-containing formulations

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11666602

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11667692

    T cell receptors recognizing HLA-CW8 restricted mutated KRAS

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11666663

    Hexameric tetrahedral RNA nanostructures

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11661439

    Peptide hydrogels and use thereof

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11654187

    Horn fly protein as active antigen in anti-horn fly vaccine for protection of bovines against horn fly infestations

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11654147

    ALK2 inhibitors and methods for inhibiting BMP signaling

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11655469

    MicroRNAs and methods of their use

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11649218

    C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11643394

    Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11642374

    Intracellular genomic transplant and methods of therapy

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11643656

    Antisense therapies for treating cancer

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11642375

    Intracellular genomic transplant and methods of therapy

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11633471

    Compositions and methods for reducing serum triglycerides

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.